These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 38165340)

  • 1. Teaching NeuroImage: Cryptococcus in a Woman With Multiple Sclerosis on Fingolimod.
    Gibson S; Mcgraw C
    Neurology; 2024 Jan; 102(2):e208027. PubMed ID: 38165340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cryptococcal meningitis in a multiple sclerosis patient treated with Fingolimod: a case report and review of imaging findings.
    Chong I; Wang KY; Lincoln CM
    Clin Imaging; 2019; 54():53-56. PubMed ID: 30544079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cryptococcal meningoencephalitis in an IgG
    Wienemann T; Müller AK; MacKenzie C; Bielor C; Weyers V; Aktas O; Hartung HP; Kremer D
    BMC Neurol; 2020 Apr; 20(1):158. PubMed ID: 32340606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cryptococcal meningitis after fingolimod discontinuation in a patient with multiple sclerosis.
    Ward MD; Jones DE; Goldman MD
    Mult Scler Relat Disord; 2016 Sep; 9():47-9. PubMed ID: 27645342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunologic mechanisms of fingolimod and the role of immunosenescence in the risk of cryptococcal infection: A case report and review of literature.
    Grebenciucova E; Reder AT; Bernard JT
    Mult Scler Relat Disord; 2016 Sep; 9():158-62. PubMed ID: 27645366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C virus (HCV) reactivation during fingolimod treatment for relapsing and remitting multiple sclerosis.
    Tagawa A; Ogawa T; Tetsuka S; Otsuka M; Hashimoto R; Kato H; Ando K; Tanabe H
    Mult Scler Relat Disord; 2016 Sep; 9():155-7. PubMed ID: 27645365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C during disease modifying therapy with Fingolimod for Relapsing Remitting Multiple Sclerosis: diagnosis and treatment.
    Aslanyan A; Anwar-Hashim Z; Siripurapu R; Mihalova T
    BMJ Case Rep; 2021 Feb; 14(2):. PubMed ID: 33637491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoimmune hemolytic anemia after treatment with fingolimod in a patient with multiple sclerosis (MS): A case report and review of the literature.
    Najdaghi S; Davani DN; Ghajarzadeh M; Shaygannejad V
    Autoimmun Rev; 2022 Dec; 21(12):103203. PubMed ID: 36220524
    [No Abstract]   [Full Text] [Related]  

  • 9. Necrotizing fungal osteomyelitis and fingolimod, 4 years after treatment with fingolimod.
    Harirchian MH; Poursadeghfard M; Sadeghipour A; Kamali H; Sarraf P
    Mult Scler Relat Disord; 2020 Jun; 41():102021. PubMed ID: 32126512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complicated Monkeypox Infection in a Patient With Multiple Sclerosis and Fingolimod Treatment.
    Müller-Jensen L; Kriedemann H; Anvari K; Huehnchen P; Siffrin V
    Neurology; 2023 Apr; 100(14):670-671. PubMed ID: 36539295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute Varicella-Zoster Virus meningitis in a multiple sclerosis patient treated with fingolimod.
    Dimitri D; Pourcher V
    Rev Neurol (Paris); 2022 Apr; 178(4):393-394. PubMed ID: 35000791
    [No Abstract]   [Full Text] [Related]  

  • 12. Conjunctival Lymphoma in a Patient on Fingolimod for Relapsing-Remitting Multiple Sclerosis.
    Christopher KL; Elner VM; Demirci H
    Ophthalmic Plast Reconstr Surg; 2017; 33(3):e73-e75. PubMed ID: 27533512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BASAL CELL CARCINOMA AND SQUAMOUS CELL CARCINOMA IN A PATIENT TREATED WITH FINGOLIMOD FOR MULTIPLE SCLEROSIS - A CASE REPORT AND LITERATURE REVIEW.
    Zięba N; Gębka-Kępińska B; Sowa P
    Wiad Lek; 2022; 75(3):735-741. PubMed ID: 35522887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fingolimod-related atrioventricular block in paediatric age group with multiple sclerosis: two case reports.
    Kum YE; Pamukçu Ö; Canpolat M
    Cardiol Young; 2023 Nov; 33(11):2384-2386. PubMed ID: 37170775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mycosis fungoides - A cutaneous lymphoproliferative disorder in a patient treated with fingolimod for multiple sclerosis.
    Nitsan Z; Kucuk N; Appel S; Tichmanovich N; Osherov M; Milo R
    J Clin Neurosci; 2018 Feb; 48():102-103. PubMed ID: 29108666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extensive molluscum contagiosum virus infection in a young adult receiving fingolimod.
    Behle V; Wobser M; Goebeler M; Stoevesandt J
    Mult Scler; 2016 Jun; 22(7):969-71. PubMed ID: 26860987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Merkel cell carcinoma in a patient with relapsing-remitting multiple sclerosis treated with fingolimod.
    Calvi A; De Riz M; Lecchi E; Pietroboni A; Ghezzi L; Scarioni M; Carandini T; Pellegrinelli A; Maurichi A; Galimberti D; Scarpini E
    J Neurol Sci; 2017 Oct; 381():296-297. PubMed ID: 28991701
    [No Abstract]   [Full Text] [Related]  

  • 18. Disseminated Cryptococcosis in a 63-year-old Patient with Multiple Sclerosis Treated with Fingolimod.
    Seto H; Nishimura M; Minamiji K; Miyoshi S; Mori H; Kanazawa K; Yasuda H
    Intern Med; 2016; 55(22):3383-3386. PubMed ID: 27853088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cryptococcal meningoencephalitis in multiple sclerosis treated with fingolimod.
    Nasir M; Galea I; Neligan A; Chung K
    Pract Neurol; 2023 Nov; 23(6):512-515. PubMed ID: 37802650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kaposi sarcoma in a fingolimod-treated patient with multiple sclerosis.
    Walker S; Brew B
    J Clin Neurosci; 2016 Sep; 31():217-8. PubMed ID: 27168454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.